Pfizer submits data to FDA showing side effects from Covid booster shots are similar to the second dose

A healthcare worker administers a third dose of the Pfizer-BioNTech Covid-19 vaccine at a senior living facility in Worcester, Pennsylvania, U.S., on Wednesday, Aug. 25, 2021.

Hannah Beier | Bloomberg | Getty Photos

Facet results from Covid booster photographs are equal to those felt after the 2d dose and in most cases have a tendency to impress younger of us, Pfizer mentioned in new info submitted to the Meals and Drug Administration because it seeks approval to distribute booster photographs all the intention thru the U.S.

Pfizer’s Section 3 peek of booster doses, which included a crew of about 300 participants from 18 to 55 years dilapidated, figured out that 63.7% skilled fatigue after getting their boosters, 48.4% had headaches, and 39.1% felt muscle anxiety. The majority of reactions to the booster had been serene or moderate in severity, the company mentioned in a 52-web allege characterize launched by the company on Wednesday. The company, along with BioNTech, are searching for the FDA’s emergency approval to administer third doses to of us 16 and over all the intention thru the U.S.

Pfizer beforehand evaluated aspect results on 2,682 2d-dose recipients ages 16 to 55 and figured out that 61.5% developed fatigue, 54% suffered headaches and 39.3% dealt with muscle anxiety.

The peek additionally tracked negative occasions among 306 booster recipients, 44 of whom developed on the least one unexpected aspect end. The most typical negative occasion, swelling of the lymph nodes, appeared in 16 of the participants.